Literature DB >> 6976144

Biphasic pattern of bacterial infection in multiple myeloma.

D G Savage, J Lindenbaum, T J Garrett.   

Abstract

Since the 1960s, gram-negative bacilli have become commoner pathogens than Streptococcus pneumoniae in multiple myeloma. To investigate this trend, we analyzed 75 bacterial infections in 57 patients with myeloma. Episodes of infection with Streptococcus pneumoniae and Haemophilus influenzae occurred at presentation, early in the disease, and in patients responding to chemotherapy. Gram-negative bacilli and Staphylococcus aureus caused 80% of infections seen after diagnosis and 92% of deaths from infection. Episodes of infection with gram-negative bacteria occurred in patients with active and advancing disease and in those responding to chemotherapy when neutropenia. Impaired antibody production may be the major immune defect leading to S. pneumoniae and H. influenzae infections whereas some additional factor or factors related to disease activity appear to predispose to gram-negative infection in myeloma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976144     DOI: 10.7326/0003-4819-96-1-47

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  24 in total

1.  Multiple myeloma.

Authors:  R M Meyer
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

Review 2.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

3.  Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Authors:  Cecilie Blimark; Erik Holmberg; Ulf-Henrik Mellqvist; Ola Landgren; Magnus Björkholm; Malin Hultcrantz; Christian Kjellander; Ingemar Turesson; Sigurdur Y Kristinsson
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

4.  Neisseria meningitidis serogroup 29E (Z') septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia).

Authors:  E Wachter; A E Brown; T E Kiehn; B J Lee; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

5.  The use of intravenous immune globulin in multiple myeloma.

Authors:  H M Chapel; M Lee
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  The effect of ranitidine on cellular immunity in patients with multiple myeloma.

Authors:  H J Nielsen; H Nielsen; F Moesgaard; N Tvede; K Klarlund; B Mansa; A Drivsholm
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 7.  Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.

Authors:  Georgios Kalambokis; Areti Theodorou; Paraskevi Kosta; Epameinondas V Tsianos
Journal:  Int J Hematol       Date:  2008-05-21       Impact factor: 2.490

8.  Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.

Authors:  Sung-Hoon Jung; Seung-Ji Kang; Hee-Chang Jang; Jae-Sook Ahn; Deok-Hwan Yang; Seung-Shin Lee; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

Review 9.  Multiple myeloma presenting with Hemophilus influenzae septic arthritis: case report and review of the literature.

Authors:  V Berthaud; J Milder; W el-Sadr
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

10.  Immunological factors and risk of infection in plateau phase myeloma.

Authors:  R M Hargreaves; J R Lea; H Griffiths; J A Faux; J M Holt; C Reid; C Bunch; M Lee; H M Chapel
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.